LU85791A1 - Compositions de bromocriptine - Google Patents

Compositions de bromocriptine Download PDF

Info

Publication number
LU85791A1
LU85791A1 LU85791A LU85791A LU85791A1 LU 85791 A1 LU85791 A1 LU 85791A1 LU 85791 A LU85791 A LU 85791A LU 85791 A LU85791 A LU 85791A LU 85791 A1 LU85791 A1 LU 85791A1
Authority
LU
Luxembourg
Prior art keywords
bromocriptine
composition according
capsule
fat
composition
Prior art date
Application number
LU85791A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU85791A1 publication Critical patent/LU85791A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU85791A 1984-02-29 1985-02-27 Compositions de bromocriptine LU85791A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions
GB8405227 1984-02-29

Publications (1)

Publication Number Publication Date
LU85791A1 true LU85791A1 (fr) 1985-12-11

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85791A LU85791A1 (fr) 1984-02-29 1985-02-27 Compositions de bromocriptine

Country Status (26)

Country Link
JP (1) JPS60202812A (es)
AT (1) AT387716B (es)
AU (2) AU586621B2 (es)
BE (1) BE901810A (es)
CA (1) CA1256374A (es)
CH (2) CH666406A5 (es)
DE (1) DE3505743C2 (es)
DK (1) DK175016B1 (es)
ES (1) ES8705223A1 (es)
FR (1) FR2560047B1 (es)
GB (1) GB8405227D0 (es)
GR (1) GR850506B (es)
HK (1) HK85490A (es)
HU (1) HU196121B (es)
IE (1) IE58235B1 (es)
IL (1) IL74459A (es)
IT (1) IT1199948B (es)
LU (1) LU85791A1 (es)
MX (1) MX9203626A (es)
NL (1) NL194231C (es)
NZ (1) NZ211247A (es)
PH (1) PH23266A (es)
PT (1) PT80015B (es)
SE (2) SE8500961L (es)
SG (1) SG69390G (es)
ZA (1) ZA851546B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
CA2156408C (en) * 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (es) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
ES540807A0 (es) 1987-05-01
NL194231B (nl) 2001-06-01
FR2560047B1 (fr) 1988-01-15
HK85490A (en) 1990-10-25
SE8500961D0 (sv) 1985-02-27
MX9203626A (es) 1992-09-01
DE3505743A1 (de) 1985-08-29
JPS60202812A (ja) 1985-10-14
HU196121B (en) 1988-10-28
PT80015B (pt) 1987-09-18
IT8547703A0 (it) 1985-02-20
FR2560047A1 (fr) 1985-08-30
DK175016B1 (da) 2004-04-26
SE462259B (sv) 1990-05-28
DK86785D0 (da) 1985-02-26
ATA58085A (de) 1988-08-15
BE901810A (fr) 1985-08-26
CH667009A5 (de) 1988-09-15
IE58235B1 (en) 1993-08-11
JPH0448776B2 (es) 1992-08-07
IE850495L (en) 1985-08-29
AU3913685A (en) 1985-09-05
NZ211247A (en) 1989-02-24
CA1256374A (en) 1989-06-27
DK86785A (da) 1985-08-30
IT8547703A1 (it) 1986-08-20
PT80015A (pt) 1986-02-10
AU586621B2 (en) 1989-07-20
NL194231C (nl) 2001-10-02
AU3500689A (en) 1989-09-14
GR850506B (es) 1985-06-28
IL74459A0 (en) 1985-05-31
HUT38254A (en) 1986-05-28
GB8405227D0 (en) 1984-04-04
ZA851546B (en) 1986-10-29
IT1199948B (it) 1989-01-05
SE8500961L (sv) 1985-08-30
IL74459A (en) 1988-12-30
AU618599B2 (en) 1992-01-02
NL8500417A (nl) 1985-09-16
DE3505743C2 (de) 1995-02-16
AT387716B (de) 1989-03-10
SG69390G (en) 1990-10-26
PH23266A (en) 1989-06-23
ES8705223A1 (es) 1987-05-01
CH666406A5 (de) 1988-07-29

Similar Documents

Publication Publication Date Title
BE1011045A3 (fr) Compositions pharmaceutiques pour la liberation controlee de substances actives.
BE1014328A7 (fr) Composition pharmaceutique orale a liberation controlee.
FR2737121A1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
FR2460667A1 (fr) Composition pharmaceutique a liberation prolongee a base d'une substance medicamenteuse solide
FR2547498A1 (fr) Comprimes de naproxen et de naproxen sodique a liberation controlee
US8784872B2 (en) Formulation for decreasing tobacco, alcohol, drug or food consumption
CH702775B1 (fr) Pastilles de gélatine douces contenant de la nicotine et procédé de préparation.
FR2512676A1 (fr) Composition a liberation commandee hydrodynamiquement equilibree
BE1000661A4 (fr) Nouvelles compositions pharmaceutiques a base de ketotifene.
BE1000496A7 (fr) Procede pour la production de preparations pharmaceutiques ayant une haute capacite de fixation de l'acide gastrique, exercant un effet retard et ayant une biodisponibilite accrue.
EP0754033B1 (fr) Composition galenique mucoadhesive heterofonctionnelle
GB2154874A (en) Bromocriptine compositions
BE1000159A5 (fr) Medicament a liberation controlee pour fournir des ions fluorure.
BE1007024A5 (fr) Compositions a activite agoniste des recepteurs analogues a 5ht1, selective.
LU85791A1 (fr) Compositions de bromocriptine
WO2001051033A1 (fr) Compositions pharmaceutiques solides pour la liberation controlee de substances actives
BE1010972A6 (fr) Composition pharmaceutique antituberculeuse et procede destine a produire ladite composition.
FR2604902A1 (fr) Compositions pharmaceutiques a liberation prolongee
FR2576787A1 (fr) Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle
BE1000265A3 (fr) Nouvelle association medicamenteuse.
EP0413694B1 (fr) Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur
EP1465607B1 (fr) Compositions pharmaceutiques a liberation modifiee
EP0911038B1 (fr) Composition anhydre à base de lactulose
JP4945043B2 (ja) モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤
FR2589732A1 (fr) Nouvelle formulation a liberation prolongee a base de pindolol